These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26930230)

  • 1. Cyclic RGDfK Peptide Functionalized Polymeric Nanocarriers for Targeting Gemcitabine to Ovarian Cancer Cells.
    Kulhari H; Pooja D; Kota R; Reddy TS; Tabor RF; Shukla R; Adams DJ; Sistla R; Bansal V
    Mol Pharm; 2016 May; 13(5):1491-500. PubMed ID: 26930230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of gemcitabine hydrochloride loaded lipid polymer hybrid nanoparticles (LPHNs): In vitro and in vivo.
    Yalcin TE; Ilbasmis-Tamer S; Takka S
    Int J Pharm; 2020 Apr; 580():119246. PubMed ID: 32205141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumor efficacy of folate modified PLGA-based nanoparticles for the co-delivery of drugs in ovarian cancer.
    Li S; Li X; Ding J; Han L; Guo X
    Drug Des Devel Ther; 2019; 13():1271-1280. PubMed ID: 31114163
    [No Abstract]   [Full Text] [Related]  

  • 4. Natural polysaccharide functionalized gold nanoparticles as biocompatible drug delivery carrier.
    Pooja D; Panyaram S; Kulhari H; Reddy B; Rachamalla SS; Sistla R
    Int J Biol Macromol; 2015 Sep; 80():48-56. PubMed ID: 26093321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of Pancreatic Cancer Therapy Efficacy by Type-1 Matrix Metalloproteinase-Functionalized Nanoparticles for the Selective Delivery of Gemcitabine and Erlotinib.
    Yin N; Yu H; Zhang X; Lv X
    Drug Des Devel Ther; 2020; 14():4465-4475. PubMed ID: 33122890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH-Sensitive Nanodrug Carriers for Codelivery of ERK Inhibitor and Gemcitabine Enhance the Inhibition of Tumor Growth in Pancreatic Cancer.
    Ray P; Dutta D; Haque I; Nair G; Mohammed J; Parmer M; Kale N; Orr M; Jain P; Banerjee S; Reindl KM; Mallik S; Kambhampati S; Banerjee SK; Quadir M
    Mol Pharm; 2021 Jan; 18(1):87-100. PubMed ID: 33231464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ameliorating the antitumor activity of gemcitabine against breast tumor using α
    Tunki L; Ganthala PD; Pooja D; Andugulapati SB; Kulhari H; Sistla R; Bhargava SK
    Drug Dev Ind Pharm; 2022 Aug; 48(8):384-396. PubMed ID: 36047536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and evaluation of folate functionalized albumin nanoparticles for targeted delivery of gemcitabine.
    Dubey RD; Alam N; Saneja A; Khare V; Kumar A; Vaidh S; Mahajan G; Sharma PR; Singh SK; Mondhe DM; Gupta PN
    Int J Pharm; 2015 Aug; 492(1-2):80-91. PubMed ID: 26165611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug carriers.
    Lammers T; Subr V; Ulbrich K; Peschke P; Huber PE; Hennink WE; Storm G
    Biomaterials; 2009 Jul; 30(20):3466-75. PubMed ID: 19304320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a lipid-coated mesoporous silica nanoparticle platform for synergistic gemcitabine and paclitaxel delivery to human pancreatic cancer in mice.
    Meng H; Wang M; Liu H; Liu X; Situ A; Wu B; Ji Z; Chang CH; Nel AE
    ACS Nano; 2015; 9(4):3540-57. PubMed ID: 25776964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designing Two-Dimensional Nanosheets for Improving Drug Delivery to Fucose-Receptor-Overexpressing Cancer Cells.
    Gupta N; Jangid AK; Singh M; Pooja D; Kulhari H
    ChemMedChem; 2018 Dec; 13(24):2644-2652. PubMed ID: 30371024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-delivery of docetaxel and gemcitabine by anacardic acid modified self-assembled albumin nanoparticles for effective breast cancer management.
    Kushwah V; Katiyar SS; Dora CP; Kumar Agrawal A; Lamprou DA; Gupta RC; Jain S
    Acta Biomater; 2018 Jun; 73():424-436. PubMed ID: 29649635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced tumor targeting of cRGD peptide-conjugated albumin nanoparticles in the BxPC-3 cell line.
    Yu X; Song Y; Di Y; He H; Fu D; Jin C
    Sci Rep; 2016 Aug; 6():31539. PubMed ID: 27515795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced antiproliferative activity of Herceptin (HER2)-conjugated gemcitabine-loaded chitosan nanoparticle in pancreatic cancer therapy.
    Arya G; Vandana M; Acharya S; Sahoo SK
    Nanomedicine; 2011 Dec; 7(6):859-70. PubMed ID: 21550422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and fabrication of dual-targeted delivery system based on gemcitabine-conjugated human serum albumin nanoparticles.
    Norouzi P; Amini M; Mottaghitalab F; Mirzazadeh Tekie FS; Dinarvand R; Mirzaie ZH; Atyabi F
    Chem Biol Drug Des; 2020 Aug; 96(2):745-757. PubMed ID: 28640541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silver nanoparticles enhance the apoptotic potential of gemcitabine in human ovarian cancer cells: combination therapy for effective cancer treatment.
    Yuan YG; Peng QL; Gurunathan S
    Int J Nanomedicine; 2017; 12():6487-6502. PubMed ID: 28919750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic Polyglycerol-Derived Nano-Architectures as Delivery Platforms of Gemcitabine for Pancreatic Cancer.
    Ray P; Ferraro M; Haag R; Quadir M
    Macromol Biosci; 2019 Jul; 19(7):e1900073. PubMed ID: 31183964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loading of Gemcitabine on chitosan magnetic nanoparticles increases the anti-cancer efficacy of the drug.
    Parsian M; Unsoy G; Mutlu P; Yalcin S; Tezcaner A; Gunduz U
    Eur J Pharmacol; 2016 Aug; 784():121-8. PubMed ID: 27181067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gemcitabine delivered by fucoidan/chitosan nanoparticles presents increased toxicity over human breast cancer cells.
    Oliveira C; Neves NM; Reis RL; Martins A; Silva TH
    Nanomedicine (Lond); 2018 Aug; 13(16):2037-2050. PubMed ID: 30189774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micellar nanoparticles loaded with gemcitabine and doxorubicin showed synergistic effect.
    Liu D; Chen Y; Feng X; Deng M; Xie G; Wang J; Zhang L; Liu Q; Yuan P
    Colloids Surf B Biointerfaces; 2014 Jan; 113():158-68. PubMed ID: 24077114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.